Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for cinnarizine (compound)


PubChem
Name: Cinnarizine
PubChem Compound ID: 1547484
Description: A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.
Molecular formula: C26H28N2
Molecular weight: 368.514 g/mol
Synonyms:
7002-58-6; EU-0100314; 1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine; 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine; Dimitronal; Stugeron; Cinnarizine Stugeron; AIDS-001605; Cinnarizine; 1-Cinnamyl-4-(diphenylmethyl)piperazine.
show more »
DrugBank
Identification
Name: Cinnarizine
Name (isomeric): DB00568
Drug Type: small molecule
Description: A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.
Brand: Stugeron, Cinaperazine, Cinazyn, Folcodal, Dimitron, Glanil, Ixertol, Labyrin, Siptazin, Midronal, Cinnageron, Lazeta, Abitrate, Spaderizine, Eglen, Stutgeron, Sepan, Cinnarizine Stugeron, Olamin, Toliman, Carecin, Aplexal, Giganten, Denapol, Dimitronal, Katoseran, Aplactan, Apotomin, Stutgin, Corathiem, Cerepar, Hilactan, Sedatromin, Mitronal, Processine, Cerebolan, Marisan, Cinnacet, Artate
Category: Histamine H1 Antagonists, Calcium Channel Blockers, Anti-Allergic Agents
CAS number: 298-57-7
Pharmacology
Indication: For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
Pharmacology:
Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonist...
show more »
Mechanism of Action: Cinnarizine inhibits contractions of vascular smooth muscle cells by blocking L-type and T-type voltage gated calcium channels. Cinnarizine has also been implicated in binding to dopamine D2 receptors, histamine H1 receptors, and muscarinic acetylcholine receptors.
Affected organisms: Humans and other mammals

Targets


Enzymes